The response of broiler chickens and turkey poults to dietary energy supplied either by fat or carbohydrates

The efficacy of fat and carbohydrates as energy sources was compared in 1- to 4- and 4- to 7-wk-old broiler chickens and in 16- to 19-wk-old turkeys. An increase in dietary energy by carbohydrate was made by a graded replacement of wheat bran by wheat. Energy was increased by fat through a graded replacement of soybean hulls with refined soybean oil. In the experiments with broiler chickens, the feed efficiency responses to added energy were observed within the entire range of dietary energy tested, with no significant differences between the responses to carbohydrate and fat as energy supplements. The growth response to energy from either source appeared to be characterized by diminishing returns in the chicken. In the 16- to 19-wk-old turkeys, the growth and feed efficiency responses were linear within the range from 2,650 to 3,250 kcal/kg. In chickens and in turkeys, the growth and feed efficiency responses to energy supplied by fat were indistinguishable from those of carbohydrates. In chickens, the fractions of abdominal fat and pectoral muscle were not affected significantly by the energy density and source.

Cloning and characterization of a calcium-sensing receptor from the hypercalcemic New Zealand white rabbit reveals unaltered responsiveness to extracellular calcium

The extracellular Ca2+ (Ca(0)2+)-sensing receptor (CaR) recently cloned from mammalian parathyroid, kidney, brain, and thyroid plays a central role in maintaining near constancy of Ca(0)2+. We previously showed that the hypercalcemia normally present in New Zealand white rabbits is associated with an elevated set point for Ca(02+)-regulated PTH release (the level of Ca(0)2+ half-maximally inhibiting hormonal secretion). This observation suggested an alteration in the Ca(02+)-sensing mechanism in the rabbit parathyroid, a possibility we have now pursued by isolating and characterizing the rabbit homolog of the CaR. The cloned rabbit kidney CaR (RabCaR) shares a high degree of overall homology (> 90% amino acid identity) with the bovine, human, and rat CaRs, although it differs slightly in several regions of the extracellular domain potentially involved in binding ligands. By Northern analysis and/or immunohistochemistry, a similar or identical receptor is also expressed in parathyroid, thyroid C cells, small and large intestine, and in the thick ascending limb and collecting ducts of the kidney. When expressed transiently in HEK293 cells and assayed functionally through CaR agonist-evoked increases in Ca(i)2+, the rabbit CaR shows apparent affinities for Ca(0)2+, Mg(0)2+, and Gd(0)3+ that are indistinguishable from those observed in studies carried out concomitantly using the human CaR. Therefore, at least as assessed by its ability to increase Ca(i)2+ when expressed in HEK293 cells, the intrinsic functional properties of the rabbit CaR cannot explain the hypercalcemia observed in vivo in the New Zealand white rabbit.

Blood system response of chickens to changes in environmental temperature

Hemodynamic changes were studied in broiler chickens during exposure to constant temperatures (10 to 35 C) or diurnal temperature cycles (10:30 C and 15:35 C), and during acute heat or cold. Packed cell volume (PCV) was significantly high at low constant temperatures (10 and 15 C), whereas at high temperatures (30 and 35 C) plasma volume (PV) was significantly high. A linear relationship between hematocrit and heart weight was observed and indicates an adaptation of heart mass to changes in cardiac output and hematocrit to meet the demands of increased basal metabolic rate. Only during the diurnal temperature cycle of 15:35 C did a significant increase in PV occur when ambient temperature (Ta) was raised form 15 to 35 C. Acute exposure of chickens to high temperature did not affect PV or PCV, but resulted in hyperthermia (44.7 +/- 0.4 C). Changes in PCV are probably related to modulation of the supply of oxygen to accommodate changes in heat production. The significant hypervolemia observed at high temperatures could occur to provide the fluid needed for heat dissipation by panting. The lack of response of the blood system to acute temperature changes may be at least partially responsible for the chickens' failure to control body temperature.

Induction of thermotolerance in chickens by temperature conditioning: heat shock protein expression

Broiler chicks were conditioned by exposure to heat stress early in life to elucidate physiological mechanisms and possible involvement of the known heat shock proteins (HSPs) in the induction of thermotolerance. Chicks were exposed to 36 +/- 1 degree C; 70-80% relative humidity (rh) for 24 hours at the age of 5 days. During conditioning, weight gain was depressed. Due to accelerated growth during the postconditioning period, a complete compensation for lost weight gain was achieved by the conditioned group. At the age of 42 days, challenge with acute heat stress of 35 +/- 1 degree C; 25-30% rh resulted in a large increase in cloacal temperature of the control chickens and by a more moderate increase in the conditioned chickens. Mortality during the thermal challenge was significantly higher in the control chickens than in the conditioned ones. Conditioning at an early age resulted in reduced plasma triiodothyronine (T3) concentration and hemodynamic changes (significant decrease in heart weight and hematocrit). The synthesis rate of 70 and 90 kDa HSPs during the first hour of heat challenge, accelerated gradually in control chickens, whereas in the conditioned chickens it accelerated only after 3 hours and in a more moderate response. These results suggest that HSP's response does not play a major role in the conditioning-induced mechanism leading to acquisition of thermotolerance in chickens.

Gene expression during cartilage differentiation in turkey tibial dyschondroplasia, evaluated by in situ hybridization

Gene expression and alkaline phosphatase (AP) activity, associated with chondrocyte differentiation, were evaluated in the epiphyses of normal and tibial dyschondroplasia (TD)-afflicted turkeys. In the normal turkey growth plate (GP), osteopontin (OPN) and type X collagen genes were expressed by the hypertrophic cells in both GP and secondary ossification center, parallel to manifestation of AP activity. Collagen type II gene expression was restricted to the nonhypertrophic chondrocytes at the upper part of the GP. OPN or collagen type X genes were not expressed within the TD lesion. However, these genes were expressed in areas proximal and distal to the lesion, suggesting that after reaching partial differentiation, chondrocytes within the developing TD lesion de-differentiate into cells that resemble chondrocytes in the prehypertrophic zone. This suggestion is supported by the observation that the cells in the lesion expressed the collagen type II gene. In some cases, the TD lesion was invaded by fibroblastlike cells that did not exhibit any AP activity or expressed the OPN gene. No lesions were observed in the secondary ossification centers.

Trials of 9-amino-20(S)-camptothecin in Boston

9-Amino-20(S)-camptothecin (9-AC) is an analog of camptothecin with limited water solubility which has shown significant preclinical activity in a variety of human solid tumor xenografts. A Phase I trial using a soluble formulation of 9-AC, given as a 72-hour continuous infusion, has been completed. Thirty-one patients with resistant cancers received 5-60 micrograms/M2/h at three week intervals. The Maximum Tolerated Dose (MTD) was 45 micrograms/M2/hour. Neutropenia was the dose limiting toxicity, with few significant non-myelosuppressive toxicities. Minor responses were seen in 3/31 patients. Pharmacokinetic studies of 9-AC lactone (closed ring) showed substantial interpatient variability with a predicted half-life of 36 hours. A phase I/II trial of the same formulation of 9-AC is ongoing in refractory leukemia. Stomatitis and diarrhea are the non-myelosuppressive dose limiting toxicities. Evidence of antineoplastic activity has been seen in 3/15 patients. A Phase II trial in previously untreated metastatic breast cancer is also underway. A Phase I trial of a colloidal dispersion formulation, not yet completed, is better tolerated with a MTD > 45 micrograms/M2/h as a 72-hour continuous infusion. Evidence of antineoplastic activity has also been demonstrated.

A novel 29-kDa chicken heat shock protein

The family of small heat shock proteins is the more variable among the highly conserved superfamily of heat shock proteins (HSP). Using a metabolic labeling procedure with tissue explants, we have detected in chickens a new member of the small HSP family with an apparent molecular weight of 29-kDa. This protein was induced in broiler chickens' heart muscle and lungs following an in vivo heat stress. The 29-kDa band appears after 3 h of heat stress, much later than the induction of HSP 90, HSP 70, and HSP 27. The late onset of induction suggests that HSP 29 plays a more specific role of a "second stage defense protein".

Intestinal uptake and metabolism of fatty acids in the chick

Uptake and metabolism of fatty acids in the duodenal mucosa of the chick was studied. In vitro incubations of a mucosal homogenate with 14C-oleic acid indicated that together with glycerides, water-soluble 14C compounds and 14CO2 were formed; the latter comprised approximately one quarter of metabolites formed. Studies in chickens introducing 14C-oleic acid into the duodenum and determining appearance of label in the cannulated pancreaticoduodenal vein and brachial artery indicated that similar processes occur in vivo, with both labeled glycerides and water-soluble compounds appearing in the blood. Quantitatively, metabolism of 14C-oleic acid to nonlipid compounds amounted to some 15% of the dose after 60 min. These findings suggest that a considerable portion of ingested fatty acids are metabolized before transport to the circulation.

Immunolocalization of osteonectin in avian tibial dyschondroplastic cartilage

Osteonectin is an acidic calcium-binding protein found in cartilage, bone matrix, vascular endothelium, and areas of tissue repair. Using immunocytochemistry, osteonectin has been localized in all zones of the normal avian epiphyseal growth plate with notably high amounts in the hypertrophic zone. In the proximal portion of this zone the staining was intracellular, while in the distal calcifying portion of the hypertrophic zone staining was both intracellular and extracellular. Osteonectin was also detected in the growth plate associated with lesions of chickens with tibial dyschondroplasia (TD). Intense intracellular staining was observed in hypertrophic chondrocytes proximal to the lesion; staining was markedly diminished in the TD lesion; extracellular matrix was devoid of staining. Staining intensity was high along the peripheral edges of the lesion that were undergoing vascularization and resorption. This was the only area in the dysplastic cartilage where staining was observed in the extracellular matrix as well as intracellularly. Similar patterns were viewed in all TD lesions examined, whether they were spontaneous or induced by dietary treatments or genetic selection.

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group

SUMMARY

Twenty-six AIDS patients were enrolled in an open label pilot study to evaluate the efficacy and toxicity of topical 1 percent ophthalmic trifluridine solution for the treatment of chronic mucocutaneous herpes simplex virus disease unresponsive to at least 10 days of acyclovir therapy. Susceptibility testing to acyclovir, trifluridine, and foscarnet was determined by plaque reduction assay. Twenty-four patients were evaluable for efficacy and 25 for toxicity analyses. Seven patients (29 percent) had complete healing of lesions. The overall estimated median time to complete healing was 7.1 weeks. An additional seven patients had > or = 50 percent reduction in lesion area. The overall estimated median time to 50 percent healing was 2.4 weeks. Ten (42 percent) patients discontinued treatment for reasons other than primary treatment failure and seven (29 percent) for failure to respond to therapy. Baseline patient characteristics associated with greater reduction in lesion area included higher Karnofsky score (p = 0.05), fewer lesions (p = 0.07), smaller lesion area (p = 0.11), and trifluridine susceptibility (p = 0.07). Eight (33 percent) patients developed new lesions outside of the treatment area while on study, reflecting the local nature of this therapy. No dose-limiting toxicity attributable to trifluridine was reported. Given the limited options for the treatment of acyclovir-resistant herpes simplex disease, topical trifluridine may be a useful alternative in selected patients.

Developmental changes in skin collagen biosynthesis pathway in posthatch male and female chickens

The developmental changes in skin collagen biosynthesis pathway in male and female chickens were evaluated. Concentration of collagen, levels of mRNA for collagen type I subunits and for lysyl hydroxylase, and the level of three lysyl oxidase-derived cross-links: dehydro-dihydroxylysinonorleucine (DHLNL), dehydro-hydroxylysinonorleucine (HLNL), and dehydro-histidinohydroxymerodesmosine (HHMD) were determined during 4 wk posthatching. Skin collagen content increased with age and was higher in males than in females. In both sexes, the expression of the genes coding for alpha 1 and alpha 2 of collagen type I decreased with age: alpha 1(I) gene expression decreased from Day 3 onwards, whereas the reduction in alpha 2(I) gene expression started 1 wk later. At all ages examined, the expression of both genes was higher in male than in female skin. Males and females lysyl hydroxylase gene expression remained low until Day 16, after which an increase in the enzyme gene expression was observed. An increase in skin HLNL content was observed from Day 3 in both sexes reaching a peak in males at Day 9 and in females 1 wk later. The DHLNL content, which was higher in males than in females at all ages tested, dramatically decreased in both male and female skin from 3 d of age, reaching its lowest level at Day 16, and remained at that low level thereafter. The skin content of HHMD in males and females followed an oscillatory behavior with higher peaks in the male skin. The results suggest that the higher tensile strength of male skin than female skin may be due to the elevated skin collagen content that resulted from increased expression in collagen type I genes on the one hand, and from the higher amounts of various collagen cross-links on the other.

Effects of diurnally cycling versus constant temperatures on chicken growth and food intake

1. Male broiler chickens were exposed in separate experiments to: (a) constant ambient temperatures (Ta) ranging between 10 and 35 degrees C; (b) 12 h:l2 h diurnal high-low temperature of 10:30 degrees C, 15:35 degrees C and 15:30 degrees C in different trials; and (c) 12 h of 30 or 35 degrees C and 12 h of variable lower temperature. 2. A progressive decline in weight gain and food intake was obtained as Ta increased from 18 to 35 degrees C. Under diurnally cycling temperature, weight gain and food intake were lower than in the average corresponding constant temperature, with the exception of chickens exposed to 15 : 30 degrees C, where weight gain and food intake were not significantly different from those of the constant average temperature. 3. As the diurnal cold period was made colder, chickens exposed during half of the diurnal cycle to high temperature (30, 35 degrees C) demonstrated a significant (P <= 0.05) increase in weight gain and food intake. 4. There was a good correlation between plasma triiodothyronine (T3) and Ta. The correlation between T3 and food intake was highly significant, but that between T3 and weight gain was poor. 5. The results indicate the difficulties in predicting the performance of broilers exposed to diurnally cycling temperatures from knowledge of the average temperature.

Induction of thermotolerance in male broiler chickens by temperature conditioning at an early age

Chicks were conditioned by exposure to heat stress (36 +/- 1 C; to 80% RH) for 24 h at the age of 5, or 5 and 7 d. During conditioning, weight gain was depressed. Due to accelerated growth during the postconditioning period, a complete compensation for lost weight gain was achieved by the group conditioned at 5 d, but only a partial compensation was obtained in the group conditioned at both 5 and 7 d. At the age of 42 d, challenge with acute heat stress (35 +/- 1 C; 20 to 30% RH) resulted in a large increase in cloacal temperature of the controls and a more moderate increase in the conditioned chickens. Mortality during the thermal challenge was significantly higher in the control than that of the previously exposed (conditioned) groups. Conditioning at an early age resulted in hemodynamic changes (significant decrease in heart weight and hematocrit) and reduced plasma triiodothyronine (T3) concentration. The results suggest that reduced T3 and hemodynamic changes may be part of the mechanism associated with improved thermotolerance by early age temperature conditioning.

Homeostatic control of plasma calcium concentration

Due to the importance of Ca2+ in the regulation of vital cellular and tissue functions, the concentration of Ca2+ in body fluids is closely guarded by an efficient feedback control system. This system includes Ca(2+)-transporting subsystems (bone, and kidney), Ca2+ sensing, possibly by a calcium-sensing receptor, and calcium-regulating hormones (parathyroid hormone [PTH], calcitonin [CT], and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3]). In humans and birds, acute Ca2+ perturbations are handled mainly by modulation of kidney Ca2+ reabsorption and by bone Ca2+ flow under PTH and possibly CT regulation, respectively. Chronic perturbations are also handled by the more sluggish but economic regulatory action of 1,25(OH2)D3 on intestinal calcium absorption. Peptide hormone secretion is modulated by Ca2+ and several secretagogues. The hormones' signal is produced by interaction with their respective receptors, which evokes the cAMP and phospholipase C-IP3-Ca2+ signal transduction pathways. 1,25 (OH)2D3 operates through a cytoplasmic receptor in controlling transcription and through a membrane receptor that activates the Ca2+ and phospholipase C messenger system. The calciotropic hormones also influence processes not directly associated with Ca2+ regulation, such as cell differentiation, and may thus affect the calcium-regulating subsystems also indirectly.

Responses of laying hens to forced molt procedures of variable length with or without light restriction

The importance of the length of the rest period and of photoperiod as components of the forced molt procedures was evaluated in 650- and 560-d-old Lohman hens. The procedure included an 8-d feed withdrawal phase and rest periods varying from 0 to 35 d, during which the birds were fed for maintenance only. In the first trial, forced molt was applied with or without omission of artificial illumination. The rest period varied between 2 and 20 d. In the second trial, all treatments included omission of artificial illumination, and a variable rest period between 0 and 35 d. Egg production ceased, after 4 to 5 d of feed withdrawal and resumed 8 to 15 d after the end of the rest period, without any consistent response to its length. Forced molt stimulated egg production rate and diminished its age-dependent rate of decline, reduced the proportion of broken and shell-less eggs, and improved shell quality. Following wide oscillations proportional to the length of the rest period, egg weight stabilized at levels similar to that of the unmolted controls. Feed intake was stimulated by forced molt to levels exceeding those of the control hens. Body weight increased during the postmolt period to levels slightly exceeding those of unmolted controls. Results of one trial show that omission of artificial illumination was essential for the full expression of the molt responses. In the other trial, production rate and shell quality were improved and the percentage of broken eggs was reduced when the length of the rest period was increased. Maximal improvements appears to have been reached with rests period of 14 to 21 d.

Growth hormone inhibits differentiation of avian epiphyseal growth-plate chondrocytes

The effect of chicken growth hormone (cGH) on the proliferation and differentiation of avian growth-plate chondrocyte was evaluated in culture. In culture, addition of ascorbic acid to the culture media caused cell differentiation. Treatment of proliferating chondrocytes with cGH caused a time-dependent increase in collagen type II gene expression together with a decrease in the appearance of osteopontin (OPN) in the medium. In addition, the ascorbic acid-dependent increase in alkaline phosphatase (AP) activity was inhibited by cGH. IGF-I, on the other hand, caused an increase in AP activity in the ascorbic acid-treated chondrocytes. In the presence of ascorbic acid, cGH did not affect collagen type II gene expression or the appearance of OPN in the medium. Proliferation of avian growth-plate chondrocytes, in contrast to mammalian chondrocytes, was not stimulated by GH alone, although the presence of cGH was essential for chondrocyte survival in long-term culture. cGH in combination with epidermal growth factor (EGF) stimulated cell proliferation. These results suggest that GH inhibits differentiation in avian growth-plate chondrocytes, thereby sustaining their proliferative state and maintaining their sensitivity to growth factors such as EGF.

Calcium metabolism and requirements of chickens are affected by growth

The interaction between growth and calcium homeostasis was studied by comparing the responses of (a) fast-growing broiler chickens (Cobb) and slow-growing Leghorns, and (b) fast-growing chickens (Cobb) fed either high energy (12.13 kJ/g) or low energy (9.2 kJ/g) diets, to dietary calcium concentration ranging between 4 and 20 g/kg). Plasma calcium increased as dietary calcium increased, reaching an apparent plateau between 0.8 and 1.5% dietary calcium, regardless of basal growth rate. Dietary calcium levels of 1.5% and higher induced hypercalcemia and hypophosphatemia in fast- but not in slow-growing chickens. Weight gain was unaffected by dietary calcium in the slow-growing Leghorns, but followed a bell-shaped response pattern in the fast-growing Cobb chickens. Growth inhibition by feeding of low energy diets changed the response pattern from a quadratic form to that of an increase towards a plateau. The response of bone ash to dietary calcium was characterized as quadratic in fast-growing chicks, changing to a pattern of increase towards a plateau in slow-growing chicks. Intestinal calbindin was suppressed by dietary calcium and was higher in the fast-growing than in the slow-growing chicks. An increase in dietary phosphorus resulted in a shift in the response curves of weight gain and bone ash and an increase in the calcium requirements. The results indicate that the response of chicks to dietary calcium and calcium requirements is markedly modified by growth rate.

Synthesis and phosphorylation of osteopontin by avian epiphyseal growth-plate chondrocytes as affected by differentiation

The regulation of synthesis and phosphorylation of osteopontin in relation to avian epiphyseal growth-plate chondrocyte differentiation was studied in situ and in culture. Osteopontin gene expression was evaluated in the tibia growth-plate of 3-week-old chickens by in situ hybridization. The gene was expressed mainly at the lower hypertrophic zone where cartilage matrix is calcified and endochondral bone formation is initiated. Within the hypertrophic region, a poorly labeled area separated the layer of osteopontin-positive hypertrophic chondrocytes from those associated with endochondral bone formation. In culture, proliferative chondrocytes show no alkaline phosphatase activity in contrast to ascorbic acid-treated chondrocytes which display the enzyme activity. Chondrocytes not treated with ascorbic acid, exhibited lower levels of osteopontin mRNA than the treated cells. The phorbol ester TPA--an activator of protein kinase C--and to a lesser extent FGF but not EGF, stimulated osteopontin gene expression. Chondrocytes secreted low levels of phosphorylated osteopontin to the medium. EGF treatment resulted in the appearance of phosphorylated osteopontin in the medium, without affecting the synthesis of other proteins. FGF and TGF beta, but not IGF-I or IGF-II, also caused phosphorylation of osteopontin. Ascorbic acid-treated chondrocytes secreted higher levels of phosphorylated osteopontin than the non-treated cells, but addition of FGF or TPA did not stimulate osteopontin phosphorylation any further. Parathyroid hormone caused a dose-dependent attenuation of osteopontin phosphorylation and inhibited the EGF-dependent osteopontin phosphorylation. The results suggest that osteopontin gene expression and phosphorylation in chondrocytes are regulated by separate mechanisms. The response to the various controlling agents varies with the state of differentiation. Both processes--the synthesis and phosphorylation of osteopontin--are under the control of local growth factors which are involved in bone growth and calcification.

Osteopontin gene expression and alkaline phosphatase activity in avian tibial dyschondroplasia

Osteopontin (OPN) gene expression and alkaline phosphatase activity were evaluated in the epiphyseal growth plates of normal chickens and in diet-induced tibial dyschdroplasia (TD)-afflicted chickens. In the normal growth plate, OPN gene was expressed by a) cells of the subperichondrial zone surrounding the articular cartilage, b) a narrow layer of hypertrophic chondrocytes at the hypertrophic zone, and c) lower hypertrophic chondrocytes at the zone of matrix calcification and endochondral bone formation. The latter two layers were separated by OPN-negative chondrocytes. Osteopontin gene was not expressed throughout the zone of articular cartilage in the nonhypertrophic or upper hypertrophic portions of the growth plate cartilage. Only at sites of calcification of the lower hypertrophic zone was the expression of the OPN gene associated with alkaline phosphatase activity. In all TD lesions, regardless of the induction procedure, the layer of chondrocytes of the lower hypertrophic zone expressing the OPN gene and the layer of OPN-negative cells separating the two areas of OPN-expressing cells were grossly enlarged. This resulted in a wide discontinuity between the chondrocytes of the lower hypertrophic zone expressing the OPN gene and the cells expressing the OPN gene that are associated with mineralization. In TD, no alkaline phosphatase activity was detected within the growth plate cartilage, but normal OPN gene expression was observed at the subperichondrium zone and at the zone of endochondral bone formation. The results of this study suggest that in the epiphyseal growth plate, OPN expression is not restricted to sites of bone calcification.

A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin

Camptothecins are the only available antitumor agents which target the nuclear enzyme topoisomerase I. 9-Aminocamptothecin (9-AC) is a water-insoluble derivative of camptothecin which has demonstrated impressive antitumor activity in preclinical models. While two other water-soluble derivatives, CPT-11 and topotecan, have successfully completed Phase I and Phase II testing, biochemical and tissue culture studies suggest that camptothecin analogues differ in characteristics which may be important in determining antitumor activity. We performed a Phase I trial of 9-AC to determine the pharmacokinetics, dose-limiting toxicity, and maximum tolerated dose of this agent when administered as a 72-h continuous i.v. infusion. Thirty-one patients with resistant solid cancers received 5-60 microgram/m2/h 9-AC for 72 h, repeated at 3-week intervals. The drug was administered in a vehicle containing dimethylacetamide, polyethylene glycol, and phosphoric acid. Blood samples were collected and the lactone (closed ring) form of 9-AC was quantitated. The maximum tolerated dose of 9-AC was determined to be 45 microgram/m2/h. Dose-limiting toxicity consisted of neutropenia. Thrombocytopenia was also prominent. There were no significant nonhematological toxicities. Minimal responses were seen in patients with gastric, colon, and non-small cell lung cancer. Although significant interpatient variation in plasma 9-AC lactone levels was observed, pooled data were fit to a two-compartment model, with a terminal half-life of 36 h. Analyses of topoisomerase protein levels in peripheral blood cells indicated decreases in topoisomerase I accompanied by increases in topoisomerase II in two of three patients. 9-AC is an active antitumor agent and may be administered safely as a 72-h infusion in patients with cancer. Although Phase II trials with a 72-h infusion of 9-AC are warranted, alternate schedules should be evaluated given the dramatic preclinical activity seen with more prolonged administrations.